TPCM
ABBV icon

Templeton & Phillips Capital Management’s AbbVie ABBV Stock Holding History

Templeton & Phillips Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+871
New +$187K 0.16% 46
2025
Q4 		– Sell
-871
Closed -$202K – 46
2025
Q3 		$202K Buy
+871
New +$177K 0.15% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Templeton & Phillips Capital Management's ABBV Position: Q2 2026 in Review

Templeton & Phillips Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 871 shares worth $219K. The stake represents 0.16% of the portfolio and ranks #46 among its holdings. This is a return to the name: Templeton & Phillips Capital Management previously reported a position in ABBV as recently as Q3 2025.

Templeton & Phillips Capital Management first reported a position in ABBV in Q3 2025 and has held it in 2 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Templeton & Phillips Capital Management held 871 shares of AbbVie worth $219K as of Q2 2026.
  • AbbVie was a new Templeton & Phillips Capital Management position in Q2 2026.
  • AbbVie made up 0.16% of Templeton & Phillips Capital Management's portfolio in Q2 2026, its #46 holding.
  • Templeton & Phillips Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 2 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Templeton & Phillips Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.